Answers to common questions about careers at Biopharmax
A Turnkey solution means Biopharmax manages the entire project lifecycle under one roof — from initial User Requirement Specifications (URS) and process design, through construction, automation, cleanroom installation, commissioning, and final cGMP validation. Clients receive a fully operational, regulatory-compliant manufacturing facility ready to produce from day one, without the complexity of coordinating multiple vendors across disciplines.
Project timelines vary based on scope, complexity, and regulatory jurisdiction, but a typical greenfield biopharmaceutical manufacturing facility takes between 18 and 36 months from URS approval to validated handover. Modular or phased projects can be delivered faster. Biopharmax’s integrated Turnkey approach — with all disciplines (process, HVAC, utilities, automation, cleanrooms, and validation) managed in-house — reduces coordination delays and minimizes overall project duration compared to multi-vendor models.
Biopharmax has delivered biopharmaceutical facility projects across Europe, North America, Asia, the Middle East, and emerging markets, with engineering offices in Israel (headquarters), the Netherlands (BV Europe), the USA, and Asia. With over 40 years of international project execution, the company brings deep knowledge of local regulatory environments, supply chain dynamics, and construction standards — ensuring consistent quality and compliance regardless of project location.
Biopharmax designs and constructs facilities in full compliance with FDA, EMA, EU GMP Annex 1, ICH Q10, and ISO 14644 cleanroom standards, as well as local regulatory requirements in each country of operation. Every project incorporates current Good Manufacturing Practice (cGMP) principles from the earliest design phase, ensuring that validation documentation — including IQ, OQ, and PQ protocols — is aligned with regulatory agency expectations globally.
Yes. Biopharmax serves the full spectrum of the biopharmaceutical industry — from early-stage biotech companies building their first cGMP facility to multinational pharmaceutical manufacturers expanding or upgrading existing production lines. For startups, Biopharmax provides strategic URS consulting and scalable facility designs that accommodate future growth. For established manufacturers, the team delivers complex multi-suite projects, technology transfers, and compliance upgrades across global sites.
Biopharmax’s commitment extends beyond facility handover. After-sales services include preventive maintenance programs, system qualification re-validation, process optimization support, regulatory inspection preparedness, spare parts management, and operator training. The company also provides technology transfer services for clients relocating or scaling production processes between facilities, ensuring continuity of compliance and operational performance throughout the product lifecycle.
